ICON applies IBM Watson Clinical Trial Matching to Oncology Clinical Trials Dublin, Ireland, 10 September, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results